Detalhe da pesquisa
1.
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
JAMA
; 325(3): 254-264, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464336
2.
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Am Heart J
; 226: 49-59, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502882
3.
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Não convencional
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-41422